Jaime’s Spanish Village Jalapeno Ranch Dressing
OFFICIAL-SOURCE RECALL · CANADA
Two lots of Teva-Pregabalin 150 mg capsules recalled Recall: Teva Canada Ltd
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryCanadaPublishedAugust 15, 2026Last updatedAugust 15, 2026Official source last checkedAugust 17, 2026 at 6:01 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline
- Manufacturer
- See official notice
- Lot number
- s-teva-pregabalin-150-mg-, s-capsules-teva-pregabali
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure. Anaphylactic reaction symptoms can be fatal and may include: Shortness of breath, wheezing, or difficulty breathing Swelling of the eyelids, face, lips, mouth, tongue, or throat Uncontrolled shaking Fainting or dizziness Trouble swallowing or speaking Widespread rash, hives Products from the recalled lots were first sold in Canada in September 2025 and expire July 31, 2027. Pregabalin is a prescription drug used in adults to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It is also used to treat pain associated with fibromyalgia. Sertraline is a prescription drug used in adults to relieve symptoms of depression, obsessive-compulsive disorder, and panic disorder. Side effects may include nausea, diarrhea, dry mouth, sleep changes, dizziness, tremors or increased sweating. Health Canada is monitoring the company's recall and implementation of corrective and preventive actions.
Hazard
Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure. Anaphylactic reaction symptoms can be fatal and may include: Shortness of breath, wheezing, or difficulty breathing Swelling of the eyelids, face, lips, mouth, tongue, or throat Uncontrolled shaking Fainting or dizziness Trouble swallowing or speaking Widespread rash, hives Products from the recalled lots were first sold in Canada in September 2025 and expire July 31, 2027. Pregabalin is a prescription drug used in adults to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It is also used to treat pain associated with fibromyalgia. Sertraline is a prescription drug used in adults to relieve symptoms of depression, obsessive-compulsive disorder, and panic disorder. Side effects may include nausea, diarrhea, dry mouth, sleep changes, dizziness, tremors or increased sweating. Health Canada is monitoring the company's recall and implementation of corrective and preventive actions.
Official recall notice
Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline
Agency: Health Canada
Official publication date: August 15, 2026
Read the official CANADA_HEALTH recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products